• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[研究血脂成分指标及血管内微循环状态对糖尿病合并缺血性心脏病患者的诊断价值]

[Diagnostic value of studying the indicators of blood lipid composition and the status of intravascular microcirculation in patients with diabetes mellitus associated with ischemic heart disease].

作者信息

Golubiatnikova G A, Koroleva T V, Kalmykova V I, Nastenko V F, Markova E S

出版信息

Ter Arkh. 1988;60(8):98-102.

PMID:3227488
Abstract

A comprehensive study of blood lipid composition and microcirculatory indices was performed in 88 patients with diabetes mellitus (DM) combined with coronary heart disease (CHD). A "syndrome" of mutual aggravation was shown to develop in the combination of DM and CHD. As a result of it the above indices were changed depending on clinical signs of each of the two diseases. Lipid metabolic and microcirculatory derangements depended mostly on a degree of compensation of carbohydrate metabolism. a DM type, the presence of diabetic angiopathies and CHD gravity.

摘要

对88例糖尿病(DM)合并冠心病(CHD)患者进行了血脂成分和微循环指标的综合研究。结果显示,DM和CHD合并会出现相互加重的“综合征”。因此,上述指标会根据两种疾病各自的临床症状而发生变化。脂质代谢和微循环紊乱主要取决于碳水化合物代谢的代偿程度、DM类型、糖尿病血管病变的存在情况以及CHD的严重程度。

相似文献

1
[Diagnostic value of studying the indicators of blood lipid composition and the status of intravascular microcirculation in patients with diabetes mellitus associated with ischemic heart disease].[研究血脂成分指标及血管内微循环状态对糖尿病合并缺血性心脏病患者的诊断价值]
Ter Arkh. 1988;60(8):98-102.
2
[Diagnostics of microcirculatory disorders in patients with diabetes mellitus type 2 and ischemic heart disease].[2型糖尿病合并缺血性心脏病患者微循环障碍的诊断]
Klin Med (Mosk). 2004;82(2):36-9.
3
[Ischemic heart disease in patients with diabetes mellitus].糖尿病患者的缺血性心脏病
Klin Med (Mosk). 1988 Jan;66(1):28-34.
4
[Quantitative characterization of the main lipid and apoprotein components of plasma lipoproteins in men with types I and II diabetes mellitus with and without coronary heart disease].[1型和2型糖尿病伴或不伴冠心病男性血浆脂蛋白主要脂质和载脂蛋白成分的定量特征分析]
Ter Arkh. 1987;59(11):18-22.
5
[Different variants of ischemic heart disease in patients with diabetes mellitus].[糖尿病患者缺血性心脏病的不同变体]
Vrach Delo. 1975 Aug(8):27-30.
6
Microvascular perfusion and transport in the diabetic heart.糖尿病心脏中的微血管灌注与转运
Microcirculation. 2000 Jun;7(3):163-81.
7
[ECG changes in long-term diabetics].[长期糖尿病患者的心电图变化]
Z Gesamte Inn Med. 1972 Dec 15;27(24):1073-6.
8
[Comparative study of peripheral circulation, lipid metabolism and hemocoagulation in families with atherosclerosis and diabetes mellitus].
Ter Arkh. 1998;70(10):10-5.
9
The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.国际糖尿病联盟和美国国家胆固醇教育计划成人治疗小组第三次报告中代谢综合征的定义在预测2型糖尿病患者冠心病方面的效用。
Diabetes Care. 2007 May;30(5):1206-11. doi: 10.2337/dc06-1484. Epub 2007 Jan 26.
10
Xuezhikang, an extract of cholestin, reduces cardiovascular events in type 2 diabetes patients with coronary heart disease: subgroup analysis of patients with type 2 diabetes from China coronary secondary prevention study (CCSPS).血脂康,一种红曲提取物,可降低2型糖尿病合并冠心病患者的心血管事件:中国冠心病二级预防研究(CCSPS)中2型糖尿病患者的亚组分析。
J Cardiovasc Pharmacol. 2007 Feb;49(2):81-4. doi: 10.1097/FJC.0b013e31802d3a58.